Placeholder Banner

BIO’s Statement on the Confirmation of Andrei Iancu to Lead the U.S. Patent and Trademark Office

February 5, 2018

Washington, D.C. (February 5, 2018) – The following statement may be attributed to BIO President & CEO James Greenwood:

“I congratulate Andrei Iancu on his Senate confirmation to fill the position of Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (PTO).

“The position of PTO Director is extraordinarily important, as it oversees a federal agency that is an indispensable element of the continued economic growth and innovation of American enterprise.

“Strong and reliable patents are the lifeblood of the biotechnology industry. They are critical in ensuring a steady stream of capital to biotechnology companies developing innovative medicines and more sustainable, bio-based energy and agricultural products. And they are essential to the technology transfer process that leads from inventions in the lab to products on the shelves. 

“I look forward to engaging with Director Iancu and his staff as BIO continues to push for balanced reforms to curb abusive anti-patent practices, protect the ability of patent owners to defend their inventions and businesses against infringement, and promote greater predictability and certainty of patent rights as a basis for investment in innovation.”

Discover More
Today, the Biotechnology Innovation Organization (BIO) submitted its comments in response to the U.S. Department of Agriculture’s (UDSA) Solicitation of Input from Stakeholders on Agricultural Innovations, part of the Department’s Agriculture…
Washington, D.C. (July 29, 2020) – The Food and Agriculture Section of the Biotechnology Innovation Organization (BIO) is pleased to announce the election of its new Board leadership. Sylvia Wulf, CEO of AquaBounty Technologies, Inc., and Brian…
Says biopharma researchers and scientists stand ready to support real solutions that will address patient drug costs, continue lifesaving science Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO),…